Results 251 to 260 of about 269,977 (355)

Expert Perspectives on a Clinical Challenge: Hematologic Malignancies and Vasculitis

Arthritis &Rheumatology, Accepted Article.
Systemic vasculitis describes a collection of rare diseases each caused by inflammation of blood vessel walls that can cause severe systemic complications [[3, 4]](#ref‐0003). The pattern of vascular inflammation and resultant damage is frequently variable and may be mimicked, or directly triggered, by infection or malignancy.
Michelle L. Robinette, Hetty E. Carraway
wiley   +1 more source

Advances in nucleic acid-based cancer vaccines. [PDF]

J Biomed Sci
Liao HC, Liu SJ.
europepmc   +1 more source

Survey sabotage: Insights into reducing the risk of fraudulent responses in online surveys

Anatomical Sciences Education, EarlyView.
Abstract Validity is a key element of many forms of research—particularly surveys, which are often used in health professions education research. A survey must accurately measure what it is intended to measure to be considered valid. This is becoming increasingly difficult in the age of artificial intelligence (AI), where “bots” (short for robots) are ...
James Bonnamy, Bethany Carr, Michelle D. Lazarus, Clifford Connell   +3 more
wiley   +1 more source

Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapy. [PDF]

Hum Vaccin Immunother
Jani CT, Manoharan A, DeMaria PJ, Bilusic M.   +3 more
europepmc   +1 more source

Cancer Vaccines in the Immunotherapy Era: Promise and Potential. [PDF]

Vaccines (Basel), 2023
Verma C, Pawar VA, Srivastava S, Tyagi A, Kaushik G, Shukla SK, Kumar V.   +6 more
europepmc   +1 more source

Dendritic cells in cancer vaccines

, 2001
Peter Brossart, Stefan Wirths, Wolfram Brugger, Lothar Kanz   +3 more
openalex   +1 more source

General practitioner consultation for postmenopausal bleeding after COVID‐19 vaccination—a self‐controlled cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims The incidence of postmenopausal bleeding (PMB) has been increasing over the past years. Little is known about the risk of PMB after COVID‐19 vaccination. Our study aimed to investigate this based on routine general practitioner (GP) healthcare data from the Netherlands.
Rana Jajou, Eugène P. van Puijenbroek, Renee Veldkamp, Jetty A. Overbeek, Florence P. A. M. van Hunsel, Agnes C. Kant   +5 more
wiley   +1 more source

Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy. [PDF]

Pharmaceutics
Delgado-Almenta V, Blaya-Cánovas JL, Calahorra J, López-Tejada A, Griñán-Lisón C, Granados-Principal S.   +5 more
europepmc   +1 more source

Appraising the visibility, relevance and impacts of clinical pharmacology

British Journal of Clinical Pharmacology, EarlyView.
Aims Clinical pharmacology (CP) used to be a strong medical and scientific field, but during the last three decades it seems to have lost some of its appeal. We reviewed the visibility, relevance and impact of CP and clinical pharmacologists across the globe and suggest ways to strengthen the discipline to address future pharmacotherapeutic challenges.
Serge Cremers, Samuel L. M. Arnold, Nilima A. Kshirsagar, Catriona Waitt, Olayinka O. Ogunleye, Lars L. Gustafsson   +5 more
wiley   +1 more source

Immunophenotyping of colon cancer for identification of potential antigens for colon cancer vaccines. [PDF]

Front Oncol
Wang X, Lai J, Wang D, Wei K, Yang J.
europepmc   +1 more source